» Articles » PMID: 25019054

What's in a Name? Compliance, Adherence and Concordance in Chronic Psychiatric Disorders

Overview
Specialty Psychiatry
Date 2014 Jul 15
PMID 25019054
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

About half or more of the patients with chronic psychiatric illnesses, either do not take their medications correctly, or completely stop taking them. The problem of poor initial compliance or adherence is often compounded by a continued decline in compliance/adherence over time. The failure to take medicines, adversely affects the outcome of treatment, and places a huge burden of wasted resources on the society. Three terms have been used to describe medication-taking among patients with chronic psychiatric disorders. Compliance is defined as "the extent to which the patient's behaviour matches the prescriber's recommendations". Though compliance has been frequently employed to describe medication-taking behaviour, it has proved problematic because it refers to a process where the clinician decides on a suitable treatment, which the patient is expected to comply with unquestioningly. Studies over the past few decades have emphasized the importance of patients' perspectives in medication-taking, based on their own beliefs, their personal circumstances, the information and resources available for them. Adherence has been used as a replacement for compliance in an effort to place the clinician-patient relationship in its proper perspective. Adherence refers to a process, in which the appropriate treatment is decided after a proper discussion with the patient. It also implies that the patient is under no compulsion to accept a particular treatment, and is not to be held solely responsible for the occurrence of non-adherence. Adherence has been defined as "the extent to which a person's behaviour, taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider". To overcome certain problems in the concept of adherence, a third term concordance has been used. The concept of concordance has evolved from a narrower view, emphasizing an agreement between the clinician and the patient, which takes into account each other's perspective on medication-taking, to a broader process consisting of open discussions with the patient regarding medication-taking, imparting information and supporting patients on long-term medication. It is a process, which entertains patients' views on medication-taking, and acknowledges that patients' views have to be respected even if they make choices, which appear to be in conflict with the clinician's views. Although none of these terms are ideal solutions to understanding the complex process of medication-taking behaviour of patients, the move from compliance to adherence and concordance represents genuine progress in this field, which puts the patient's perceptions at the centre of the whole process.

Citing Articles

Empowering the Patient With Chronic Obstructive Pulmonary Disease: Optimizing Inhalation Technique.

Castro S, Moura J, Dias F, Magalhaes D, Vasconcelos I, Abreu A Cureus. 2025; 17(1):e77019.

PMID: 39912034 PMC: 11798567. DOI: 10.7759/cureus.77019.


A Systematic Review of Controlled Trials: Can Patient Adherence to Antibiotics Be Improved Through Pharmaceutical Communication-Based Interventions?.

Pires C Pharmacy (Basel). 2024; 12(6).

PMID: 39728843 PMC: 11677000. DOI: 10.3390/pharmacy12060178.


Identifying the Relative Importance of Factors Influencing Medication Compliance in General Patients Using Regularized Logistic Regression and LightGBM: Web-Based Survey Analysis.

Iino H, Kizaki H, Imai S, Hori S JMIR Form Res. 2024; 8():e65882.

PMID: 39715551 PMC: 11704655. DOI: 10.2196/65882.


AI technology to support adaptive functioning in neurodevelopmental conditions in everyday environments: a systematic review.

Perry N, Sun C, Munro M, Boulton K, Guastella A NPJ Digit Med. 2024; 7(1):370.

PMID: 39702672 PMC: 11659516. DOI: 10.1038/s41746-024-01355-7.


Medication Management Initiatives Using Wearable Devices: Scoping Review.

Iino H, Kizaki H, Imai S, Hori S JMIR Hum Factors. 2024; 11:e57652.

PMID: 39602520 PMC: 11612519. DOI: 10.2196/57652.


References
1.
Acosta F, Hernandez J, Pereira J, Herrera J, Rodriguez C . Medication adherence in schizophrenia. World J Psychiatry. 2013; 2(5):74-82. PMC: 3782179. DOI: 10.5498/wjp.v2.i5.74. View

2.
Adams J, Scott J . Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000; 101(2):119-24. DOI: 10.1034/j.1600-0447.2000.90061.x. View

3.
Velligan D, Weiden P, Sajatovic M, Scott J, Carpenter D, Ross R . The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009; 70 Suppl 4:1-46. View

4.
Blackwell B . Treatment adherence. Br J Psychiatry. 1976; 129:513-31. DOI: 10.1192/bjp.129.6.513. View

5.
Haynes R, Ackloo E, Sahota N, McDONALD H, Yao X . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI: 10.1002/14651858.CD000011.pub3. View